Filing Details
- Accession Number:
- 0001181431-10-060711
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-12-10 13:40:54
- Reporting Period:
- 2010-12-10
- Filing Date:
- 2010-12-10
- Accepted Time:
- 2010-12-10 13:40:54
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 811641 | Immucell Corp | ICCC | In Vitro & In Vivo Diagnostic Substances (2835) | 010382980 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1136546 | H Joseph Crabb | C/O Immucell Corp 56 Evergreen Drive Portland ME 04103 | Vice President & Cso | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $0.10 Per Share | Acquisiton | 2010-12-10 | 1,000 | $2.00 | 113,111 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Incentive stock options (right to buy) | Disposition | 2010-12-10 | 1,000 | $0.00 | 1,000 | $2.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2003-12-13 | 2010-12-13 | No | 4 | X | Direct |
Billionaire Hedge Funds
